Glucagon-like peptide-1 agonism - GLP-1, common in obesity medicines - is not essential to weight management, according to preclinical research led by Richard DiMarchi and Matthias Tschöp, with funding from their startup company Bluewater Biosciences.
That’s so pedantic, but yes, they’re a treatment for an uncontrollable appetite. Do you mean to suggest that you’re against medical treatments which are not cures?